Form 4: Prothena Corp Public Ltd Co: Chief Regulatory Officer Acquires Stock Options
SEC Filing Form 4
Carol D. Karp, Chief Regulatory Officer of Prothena Corp Public Ltd Co, reports the acquisition of stock options for 107,500 ordinary shares.
Summary
- Carol D. Karp, the Chief Regulatory Officer of Prothena Corp Public Ltd Co, filed a Form 4.
- The filing reports the acquisition of stock options to purchase 107,500 ordinary shares on March 5, 2025.
- The exercise price of the options is $14.95.
- The options vest over a four-year period, starting March 5, 2026, with 25% vesting initially and the remainder vesting monthly thereafter, contingent upon continued employment.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a routine disclosure of stock option grants.
Positives
- The acquisition of stock options by a key officer may indicate confidence in the company's future performance.
Industry Context
Form 4 filings are standard practice and provide transparency into insider transactions, allowing investors to monitor the actions of company executives and their potential impact on the stock.
Stakeholder Impact
- Shareholders can monitor insider activity through this filing.
Key Dates
| Date | Description |
|---|---|
| 03/05/2025 | Date of stock option grant. |
| 03/05/2026 | First vesting date for 25% of the stock options. |
| 03/07/2025 | Date of Form 4 filing. |
| 03/05/2035 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.